Keisuke Yamazaki
Department Of Head And Neck Surgery
Niigata, Japan
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.
Journal: Head & neck
Published: March 28, 2026
Subtype Change and Treatment Refractoriness at the Time of Recurrence in a Patient with Breast Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026
MEG3 Promoter Methylation and F11 Receptor (F11R) Overexpression Define a High-Risk Subtype of Diabetic Pancreatic Cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 16, 2025
Online video training for managing postoperative neck hemorrhage.
Journal: Auris, nasus, larynx
Published: March 16, 2025
The impact of detecting and autotransplanting parathyroid gland with near-infrared imaging during total laryngectomy with total thyroidectomy.
Journal: Auris, nasus, larynx
Published: February 19, 2025
Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 Variants.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 17, 2025
Concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with head and neck squamous cell carcinoma: survival analysis based on 2-year follow-up data.
Journal: International journal of clinical oncology
Published: January 04, 2025
Type 2 diabetes alters quiescent pancreatic stellate cells to tumor-prone state.
Journal: JCI insight
Published: September 25, 2024
Moderate cryptoxanthin intake correlates with maintenance of a proper PINT index in a general Japanese population.
Journal: Nutritional neuroscience
Published: July 25, 2024
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).
Journal: Frontiers in immunology
Published: July 14, 2024
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy.
Journal: Oral oncology
Published: July 06, 2024
Last Updated: 09/26/2026